ConductScience.org, home

Trial · NCT07892235

Effectiveness of Oil Pulling Using Oils in Comparison With Mouthwash for Gingivitis

NCT07892235, Not applicable, Not yet recruiting, Bahria University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Effectiveness of Oil Pulling Using Oils in Comparison With Mouthwash for Gingivitis. Trials, record NCT07892235. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07892235

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Effectiveness of Oil Pulling Using Oils in Comparison With Mouthwash for Gingivitis
NCT number
NCT07892235
Status
Not yet recruiting
Phases
Not applicable
Enrollment
45 participants, estimated
Lead sponsor
Bahria University
Conditions
Gingivitis
Interventions
coconut oil, Sesame Oil, 0.2% Chlorhexidine Mouthwash
First posted
2026-10-23
Last updated
2026-10-27

Source ClinicalTrials.gov

Registered outcomes7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in Silness and Loe Plaque Index (PI) ScoreBaseline (Day 0), Week 4 (Day 28), and Week 8 (Day 56)
valuation of dental plaque accumulation (thickness of bacterial biofilm at the gingival margin) measured across 4 tooth surfaces (buccal, lingual, mesial, distal) and averaged across examined teeth. Score ranges from 0 to 3 (0 = No plaque, 1 = Thin film detectable by probing, 2 = Moderate deposits visible to naked eye, 3 = Abundant heavy plaque buildup). Lower scores indicate better oral hygiene.
PrimaryChange in Gingival Index (GI) Score by Loe and SilnessBaseline (Day 0), Week 4 (Day 28), and Week 8 (Day 56)
Assessment of gingival inflammation severity evaluated across 4 tooth surfaces based on color, consistency, and bleeding on gentle probing. Score ranges from 0 to 3 (0 = Normal gingiva with no inflammation, 1 = Mild inflammation with slight erythema and no bleeding, 2 = Moderate inflammation with redness and bleeding on probing, 3 = Severe inflammation with marked redness, edema, and tendency to spontaneous bleeding). Lower scores indicate reduced gingival inflammation.
SecondaryChange in Winkel Tongue Coating Index (WTCI) ScoreBaseline (Day 0), Week 4 (Day 28), and Week 8 (Day 56)
Measurement of bacterial biofilm accumulation on the dorsum of the tongue across 6 zones (3 posterior, 3 anterior). Each zone is scored from 0 (no coating) to 2 (heavy thick coating with no pink tongue visible). Total score range is 0 to 12 (0 = no coating, 1-3 = mild, 4-6 = moderate, 7-9 = heavy, 10-12 = severe coating). Lower scores indicate reduced tongue biofilm accumulation.
SecondaryChange in Modified Lobene Stain Index (MLSI) ScoreBaseline (Day 0), Week 4 (Day 28), and Week 8 (Day 56)
Evaluation of extrinsic tooth staining. Calculated per tooth as Stain Intensity (0 = no stain to 3 = heavy dark brown/black stain) multiplied by Stain Area (0 = no stain to 3 = \> 2/3 of surface covered). Total mean MLSI score ranges from 0 to 9 per tooth (0 = clean enamel, 0.1-1.0 = mild staining, 1.1-2.0 = moderate staining, 2.1-3.0+ = severe staining). Lower scores indicate less extrinsic discoloration.
SecondaryChange in Salivary pH LevelBaseline (Day 0), Week 4 (Day 28), and Week 8 (Day 56)Measurement of oral cavity salivary pH using standardized pH paper indicator strips matched against a standardized color chart (range 1.0 to 14.0).
SecondaryChange in Oral Health Impact Profile-14 (OHIP-14) questionnare Total ScoreBaseline (Day 0), Week 4 (Day 28), and Week 8 (Day 56)
Patient-reported questionnaire assessing oral health-related quality of life across 7 conceptual domains (functional limitation, physical pain, psychological discomfort, physical disability, psychological disability, social disability, handicap). 14 items rated on a 5-point Likert scale (0 = Never to 4 = Very Often). Total score ranges from 0 to 56, where higher scores indicate greater negative impact on oral health quality of life.
SecondaryPatient-Reported Visual Analog Scale (VAS) Scores and SatisfactionBaseline (Day 0), Week 4 (Day 28), and Week 8 (Day 56)
Patient-reported ratings of dental sensitivity, soft tissue pain, and product satisfaction evaluated on a 0 to 10 Visual Analog Scale (0 = no symptoms / not satisfied, 10 = severe symptoms / very satisfied).

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers7

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
9332805BACKGROUNDPubMed
37635453BACKGROUNDPubMed
38571699BACKGROUNDPubMed
38831568BACKGROUNDPubMed
39786483BACKGROUNDPubMed
39926945BACKGROUNDPubMed
41140336BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07892235

GET https://conductscience.org/api/trials/v1/NCT07892235/registered